Elcelyx Therapeutics
San Diego, US · Delaware corporation · 1 known investors
Find your way into Elcelyx Therapeutics
99 people in our graph share verified history with the Elcelyx Therapeutics team — schools, employers, funds. One of them is your warm intro.
Kyle Dohertyunlockedknows Alain D. Baron · together at Morgenthaler (overlapped)
×3knows the team · via McGill University
×4knows the team · via Lightstone Ventures
×3knows the team · via Morgenthaler
knows the team · via Medical College of Georgia at Augusta University
Founders & leadership
AD
Alain D. BaroninFounderAlain D. Baron is an executive and physician-scientist with experience in life sciences and drug development.
MR
Martin R. BrownExecutive
MW
MARK WIGGINSExecutive
MF
Mark FinemanNamed on SEC filing
Board
RE
Ralph E. ChristoffersonBoard director
RJ
Richard J. BarryBoard director
LT
Liang TsuiBoard director
JG
Jim GlasheenBoard director
BB
GG
Ginger GrahamBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$51.1M disclosed across 4 rounds · 2013–2018
▶$476.5KraisedNov 2018 · 2 investors · BiotechnologyRule 506(b)
▶$476.5KraisedNov 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ginger GrahamDirector
- Jim GlasheenDirector
- Mark FinemanExecutive Officer
- Christoffersen RalphDirector
- Richard BarryDirector
- Sandy MahatmeDirector
- Bosun HauDirector
- Alain BaronExecutive Officer, Director
- Liang TsuiDirector
- Jay SherwoodExecutive Officer
- Offering amount
- $1M
- Amount sold
- $476.5K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.1MraisedOct 2015 · 13 investors · BiotechnologyRule 506(b)
▶$20.1MraisedOct 2015 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ralph E. ChristoffersonDirector
- Richard J. BarryDirector
- Liang TsuiDirector
- Martin R. BrownExecutive Officer
- Alain D. BaronExecutive Officer, Director
- Ginger GrahamDirector
- Mark FinemanExecutive Officer
- Jim GlasheenDirector
- Offering amount
- $40.2M
- Amount sold
- $20.1M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.8MraisedFeb 2015 · 8 investors · BiotechnologyRule 506(b)
▶$5.8MraisedFeb 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark FinemanExecutive Officer
- Jim GlasheenDirector
- Richard J. BarryDirector
- Brook ByersDirector
- Ginger GrahamDirector
- Martin R. BrownExecutive Officer
- Ralph E. ChristoffersonDirector
- Mark WigginsExecutive Officer
- Alain D. BaronExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $5.8M
- Proceeds to insiders
- $1.3M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.7MraisedFeb 2014 · 7 investors · BiotechnologyRule 506(b)
▶$24.7MraisedFeb 2014 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- BROOK BYERSDirector
- GINGER GRAHAMDirector
- RALPH E. CHRISTOFFERSONDirector
- MARK WIGGINSExecutive Officer
- MARTIN R. BROWNExecutive Officer
- RICHARD J. BARRYDirector
- JIM GLASHEENDirector
- MARK FINEMANExecutive Officer
- ALAIN D. BARONExecutive Officer, Director
- Offering amount
- $24.7M
- Amount sold
- $24.7M
- First sale
- Feb 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Elcelyx Therapeutics?
- Elcelyx Therapeutics was founded by Alain D. Baron.
- Who are Elcelyx Therapeutics's investors?
- Elcelyx Therapeutics's investors include Kleiner Perkins.
- How much funding has Elcelyx Therapeutics raised?
- Elcelyx Therapeutics has disclosed $51.1M raised across 4 rounds.
- Where is Elcelyx Therapeutics headquartered?
- Elcelyx Therapeutics is headquartered in San Diego, US.